The genetic epidemiology of multiple sclerosis

Journal of Neuroimmunology

Volumn 143, Issue 1-2, 2003, Pages 7-12

  Kenealy, Shannon J ^a   Pericak Vance, Margaret A ^b   Haines, Jonathan L ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Central neurons system; Genetic epidemiology; Multiple sclerosis

Indexed keywords

CONFERENCE PAPER; DISEASE COURSE; GENE IDENTIFICATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC EPIDEMIOLOGY; GENETIC LINKAGE; HEREDITY; HUMAN; MULTIPLE SCLEROSIS; PATHOGENICITY; POPULATION; PREVALENCE; PRIORITY JOURNAL; SEGREGATION ANALYSIS;

EID: 0242352466     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.08.005     Document Type: Conference Paper

References (56)

1. Akesson E.et al. A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immun. 3(5):2002;279-285.
2. Ban M.et al. A genome screen for linkage in Australian sibling-pairs with multiple sclerosis. Genes Immun. 3(8):2002;464-469.
3. Barcellos L.F.et al. Genetic basis for clinical expression in multiple sclerosis. Brain. 125(Pt. 1):2002;150-158.
4. Bertrams J., Kuwert E. HL-A antigen frequencies in multiple sclerosis. Significant increase of HL-A3, HL-A10 and W5, and decrease of HL-A12. Eur. J. Neurol. 7(1):1972;74-78.
5. Broadley S.et al. A genome screen for multiple sclerosis in Italian families. Genes Immun. 2(4):2001;205-210.
6. Chapman J., Sylantiev C., Nisipeanu P., Korczyn A.D. Preliminary observations on APOE epsilon4 allele and progression of disability in multiple sclerosis. Arch. Neurol. 56(12):1999;1484-1487.
7. Chapman J., Vinokurov S., Achiron A., Karussis D.M., Mitosek-Szewczyk K., Birnbaum M., Michaelson D.M., Korczyn A.D. APOE genotype is a major predictor of long-term progression of disability in MS. Neurol. 56(3):2001;312-316.
8. Chataway J.et al. The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain. 121(Pt. 10):1998;1869-1887.
9. Compston D.A., Batchelor J.R., McDonald W.I. B-lymphocyte alloantigens associated with multiple sclerosis. Lancet. 2:1976;1261-1265.
10. Cook S.D., Cromarty J.I., Tapp W., MacDonald J., Tapp W., Poskanzer D., Dowling P.C. Declining incidence of multiple sclerosis in the Shetland Islands: an update. Acta Neurol. Scand. 77:1998;148-151.
11. Corradu F.et al. A genome screen for multiple sclerosis in Sardinian multiplex families. Eur. J. Hum. Genet. 9(8):2001;621-626.
12. D'Alfonso S.et al. An attempt of identifying MS-associated loci as a follow-up of a genomic linkage study in the Italian population. J. Neurovirol. 6(Suppl. 2):2000;S18-S22.
13. Ebers G.C., Sadovnick A.D., Risch N.J. A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature. 377(6545):1995;150-151.
14. Ebers G.C.et al. A full genome search in multiple sclerosis. Nat. Genet. 13:1996;472-476.
15. Eoli M., Pandolfo M., Milanese C., Gasparini P., Salmaggi A., Zeviani M. The myelin basic protein gene is not a major susceptibility locus for multiple sclerosis in Italian patients. J. Neurol. 241(10):1994;615-619.
16. Evangelou N., Jackson M., Beeson D., Palace J. Association of the APOE epsilon4 allele with disease activity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 67(2):1999;203-205.
17. Fazekas F.et al. Apolipoprotein E genotype related differences in brain lesions of multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 69(1):2000;25-28.
18. Fazekas F.et al. Apolipoprotein E epsilon 4 is associated with rapid progression of multiple sclerosis. Neurol. 57(5):2001;853-857.
19. Genain C.P., Cannella B., Hauser S.L., Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 5:1999;170-175.
20. Goodkin D.E.et al. Diagnostic criteria for multiple sclerosis research involving multiply affected families. Arch. Neurol. 48:1991;805-807.
21. Haile R.W., Iselius L., Hodge S.E., Morton N.E., Detels R. Segregation and linkage analysis of 40 multiplex multiple sclerosis families. Hum. Hered. 31(4):1981;252-258.
22. Haines J.L., Terwedow H.A., Burgess K., Pericak-Vance M.A., Rimmler J.B., Martin E.R., Oksenberg J.R., Lincoln R., Zhang D.Y., Banatao D.R., Gatto N., Goodkin D.E., Hauser S.L. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum. Mol. Genet. 7:1998;1229-1234.
23. Hauser S.L., Goodkin D.E. Multiple sclerosis and other demyelinating diseases. Fauci A.et al. Harrison's Principle of Internal Medicine. 14th ed. 1998;2409-2418 McGraw Hill, New York.
24. Hanash S. Disease proteomics. Nature. 422(6928):2003;226-232.
25. Høgh P.et al. Apolipoprotein E and multiple sclerosis: impact of the epsilon-4 allele on susceptibility, clinical type and progression rate. Mult. Scler. 6(4):2000;226-230.
26. Kuokkanen S.et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. 61:1997;1379-1387.
27. Ligers A.et al. Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis. Am. J. Hum. Genet. 69(4):2001;900-903.
28. Lucchinetti C.et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47:2000;707-717.
29. Martin E.R.et al. A test for linkage and association in general pedigrees: the pedigree disequilibrium test. Am. J. Hum. Genet. 67(1):2000;146-154.
30. Mumford G.L.et al. The British Isles survey of multiple sclerosis in twins. Nat. Genet. 13:1994;469-476.
31. Naito S., Manerow N., Mickey M.R., Terasaki P.I. Multiple sclerosis: association with HL-A3. Tissue Antigens. 2:1972;1-4.
32. Pericak-Vance M.A., Haines J.L. Genetic susceptibility in Alzheimer disease. Trends Genet. 11:1995;504-508.
33. Pericak-Vance M.A.et al. Identification of novel genes in late-onset Alzheimer's disease. Exp. Gerentol. 35(9-10):2000;1343-1352.
34. Polymeropoulos M.H.et al. Mapping of a gene for Parkinson's disease to chromosome 4q21-23. Science. 274:1996;1197-1199.
35. Raine C.S., Cannella B., Hauser S.L., Genain C.P. Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation. Ann. Neurol. 46:1999;144-160.
36. Risch N. Assessing the role of HLA-linked and unlinked determinants of disease. Am. J. Hum. Genet. 40:1987;1-14.
37. Robertson N.P., Fraser M., Deans J.et al. Age adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain. 119:1996;449-455.
38. Rose J., Gerken S., Lynch S., Pisani P., Varvil T., Otterud B., Leppert M. Genetic susceptibility in familial multiple sclerosis not linked to the myelin basic protein gene. Lancet. 341(8854):1993;1179-1181.
39. Sadovnick A.D., Ebers G.C. Genetics of multiple sclerosis. Neurol. Clin. 13:1995;99-118.
40. Sadovnick A.D.et al. A population based study of multiple sclerosis in twins: update. Ann. Neurol. 33:1993;281-285.
41. Sadovnick A.D.et al. Evidence for genetic basis of multiple sclerosis. Lancet. 347:1996;1728-1730.
42. Sawcer S.et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat. Genet. 13:1996;464-468.
43. Schmidt S.et al. Association of polymorphisms in the apolipoprotein E region with susceptibility to and progression of multiple sclerosis. Am. J. Hum. Genet. 70:2002;708-717.
44. Scott W.K.et al. Genetic complexity and Parkinson's disease. Science. 277:1997;387-388.
45. Scott W.K.et al. Complete genomic screen in Parkinson disease: evidence for multiple genes. JAMA. 286(18):2001;2239-2244.
46. Sherman S.L., Haile R.W., MacLean C.J., Yee S. Combined segregation and linkage analysis of multiple sclerosis. Genet. Epidemiol. Suppl. 1:1986;393-398.
47. Spielman R.S., Ewens W.J. A sibship test for linkage in the presence of association: the sib transmission/disequilibrium test. Am. J. Hum. Genet. 61:1998;450-458.
48. Spielman R.S., McGinnis R.E., Ewens W.J. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am. J. Hum. Genet. 52:1993;506-516.
49. Tefferi A., Bolander M.E., Ansell S.M., Wieben E.D., Spelsberg T.C. Primer on medical genomics: Part III. Microarray experiments and data analysis. Mayo Clin. Proc. 77(9):2002;927-940.
50. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nat. Genet. 13:1996;469-471.
51. Linkage of the MHC to familial multiple sclerosis suggests genetic heterogeneity. Hum. Mol. Genet. 7:1998;1229-1234.
52. Genetic basis for clinical expression in multiple sclerosis. Brain. 125:2002;150-158.
53. Tienari P.J., Wikstrom J., Sajantila A., Palo J., Peltonen L. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Lancet. 340(8826):1992;987-991.
54. Vandevyver C., Stinissen P., Cassiman J.J., Raus J. Myelin basic protein gene polymorphism is not associated with chronic progressive multiple sclerosis. J. Neuroimmunol. 52(1):1994;97-99.
55. Wise L.H., Lanchbury J.S., Lewis C.M. Meta-analysis of genomic searches. Ann. Hum. Genet. 63(Part 3):1999;263-272.
56. Yu Y.L., Woo E., Hawkins B.R.et al. Multiple sclerosis amongst Chinese in Hong Kong. Brain. 112:1989;1445-1467.